Literature DB >> 23695190

Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors.

M Pedroni1, C Di Gregorio, L Cortesi, L Reggiani Bonetti, G Magnani, M L Simone, V Medici, C Priore Oliva, M Marino, M Ponz de Leon.   

Abstract

Germline mutations in BRCA1 and BRCA2 genes predispose to hereditary breast cancer, whereas carriers of mutations in any of the mismatch repair genes (MMR; hMLH1, hMSH2, hMSH6, hPMS2) are highly susceptible to Lynch syndrome. In the present study, we describe a woman affected by unilateral breast cancer at the age of 35 years. After 4 years, during the follow-up she developed synchronous (and asymptomatic) endometrial cancer, ovarian carcinoma and renal clear cell carcinoma. After 7 years (at age 46), the patient developed an infiltrating carcinoma of the contralateral breast and died in a few months of metastatic disease. Initial investigations led to the detection of a constitutional mutation in the BRCA1 gene. The extended genealogical tree disclosed a suspected history of colorectal carcinoma in the maternal branch. Endometrial cancer of the proband was investigated for microsatellite instability (MSI) and immunohistochemical expression of MLH1, MSH2 and MSH6 proteins. An high MSI status and lack of expression of MLH1 protein were detected. hMLH1 gene sequencing revealed the presence of a constitutional mutation, which was also found in the mother of the proband. Loss of the wild-type hMLH1 allele was detected in both breast tumors, thus suggesting that the MMR defect contributed to the development of the breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695190     DOI: 10.1007/s10151-013-1030-y

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  24 in total

1.  Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?

Authors:  H F Vasen; H Morreau; J W Nortier
Journal:  Am J Hum Genet       Date:  2001-06       Impact factor: 11.025

2.  Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States.

Authors:  G Kurzawski; J Suchy; J Kładny; K Safranow; A Jakubowska; P Elsakov; V Kucinskas; J Gardovski; A Irmejs; H Sibul; T Huzarski; T Byrski; T Debniak; C Cybulski; J Gronwald; O Oszurek; J Clark; S Góźdź; S Niepsuj; R Słomski; A Pławski; A Łacka-Wojciechowska; A Rozmiarek; Ł Fiszer-Maliszewska; M Bebenek; D Sorokin; M Stawicka; D Godlewski; P Richter; I Brozek; B Wysocka; A Jawień; Z Banaszkiewicz; J Kowalczyk; D Czudowska; P E Goretzki; G Moeslein; J Lubiński
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

3.  Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma.

Authors:  A Borg; J Isola; J Chen; C Rubio; U Johansson; B Werelius; A Lindblom
Journal:  Int J Cancer       Date:  2000-03-15       Impact factor: 7.396

4.  Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.

Authors:  H Ruffner; C A Joazeiro; D Hemmati; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 5.  Hereditary ovarian cancer: molecular genetics and clinical implications.

Authors:  J Boyd; S C Rubin
Journal:  Gynecol Oncol       Date:  1997-02       Impact factor: 5.482

6.  Evidence for breast cancer as an integral part of Lynch syndrome.

Authors:  Nicole Buerki; Lucienne Gautier; Michal Kovac; Giancarlo Marra; Mauro Buser; Hansjakob Mueller; Karl Heinimann
Journal:  Genes Chromosomes Cancer       Date:  2011-10-27       Impact factor: 5.006

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 8.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

9.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

10.  Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer.

Authors:  Karin Kast; Teresa M Neuhann; Heike Görgens; Kerstin Becker; Katja Keller; Barbara Klink; Daniela Aust; Wolfgang Distler; Evelin Schröck; Hans K Schackert
Journal:  BMC Cancer       Date:  2012-11-20       Impact factor: 4.430

View more
  6 in total

Review 1.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

2.  Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.

Authors:  Caroline Goehringer; Christian Sutter; Matthias Kloor; Johannes Gebert; Emily P Slater; Monika Keller; Irmgard Treiber; Petra Ganschow; Martina Kadmon; Ute Moog
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

3.  Concurrent Germline BRCA1/2 and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options.

Authors:  Muhammet Ozer; Megha Ranganathan; Nicolas Lecomte; Juan M Schvartzman; Henry S Walch; Walid K Chatila; Jungeui Hong; Maria I Carlo; Michael F Walsh; Margaret Sheehan; Diana Mandelker; Ozge Ceyhan-Birsoy; Anna Maio; Yelena Kemel; Christine A Iacobuzio-Donahue; Eileen M O'Reilly; Kenneth H Yu
Journal:  JCO Precis Oncol       Date:  2022-06

4.  Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.

Authors:  Ido Laish; Eitan Friedman; Gili Levi-Reznick; Inbal Kedar; Lior Katz; Zohar Levi; Naama Halpern; Shani Parnasa; Aasem Abu-Shatya; Elizabeth Half; Yael Goldberg
Journal:  Breast Cancer Res Treat       Date:  2021-06-04       Impact factor: 4.872

5.  The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance.

Authors:  Elizabeth Varga; Elizabeth C Chao; Nicholas D Yeager
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

6.  A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome.

Authors:  Muhammad U Rashid; Humaira Naeemi; Noor Muhammad; Asif Loya; Muhammed A Yusuf; Jan Lubiński; Anna Jakubowska; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2016-07-12       Impact factor: 2.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.